K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension
- PMID: 21311022
- PMCID: PMC3371087
- DOI: 10.1126/science.1198785
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension
Abstract
Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K(+)) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na(+)) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca(2+)) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na(+) conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K(+) channel selectivity in constitutive cell proliferation and hormone production.
Figures




Comment in
-
Medicine. The genetics of primary aldosteronism.Science. 2011 Feb 11;331(6018):685-6. doi: 10.1126/science.1202887. Science. 2011. PMID: 21310991 No abstract available.
Similar articles
-
New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.Curr Opin Nephrol Hypertens. 2013 Mar;22(2):141-7. doi: 10.1097/MNH.0b013e32835cecf8. Curr Opin Nephrol Hypertens. 2013. PMID: 23318698 Review.
-
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.J Clin Endocrinol Metab. 2014 Sep;99(9):E1765-73. doi: 10.1210/jc.2014-1927. Epub 2014 Jul 24. J Clin Endocrinol Metab. 2014. PMID: 25057880 Free PMC article.
-
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30. Hypertension. 2014. PMID: 24082052
-
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.Hypertension. 2020 Apr;75(4):1034-1044. doi: 10.1161/HYPERTENSIONAHA.119.14177. Epub 2020 Mar 2. Hypertension. 2020. PMID: 32114847 Free PMC article.
-
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151. Clin Exp Pharmacol Physiol. 2013. PMID: 23829355 Free PMC article. Review.
Cited by
-
Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.Medicine (Baltimore). 2015 Apr;94(16):e708. doi: 10.1097/MD.0000000000000708. Medicine (Baltimore). 2015. PMID: 25906099 Free PMC article.
-
TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.Hypertension. 2012 May;59(5):999-1005. doi: 10.1161/HYPERTENSIONAHA.111.189662. Epub 2012 Apr 9. Hypertension. 2012. PMID: 22493079 Free PMC article.
-
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study.Sci Rep. 2023 Dec 11;13(1):21722. doi: 10.1038/s41598-023-47967-z. Sci Rep. 2023. PMID: 38081870 Free PMC article.
-
Pathogenesis and treatment of primary aldosteronism.Nat Rev Endocrinol. 2020 Oct;16(10):578-589. doi: 10.1038/s41574-020-0382-4. Epub 2020 Jul 28. Nat Rev Endocrinol. 2020. PMID: 32724183 Review.
-
Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.Proc Natl Acad Sci U S A. 2013 May 7;110(19):7838-43. doi: 10.1073/pnas.1304592110. Epub 2013 Apr 1. Proc Natl Acad Sci U S A. 2013. PMID: 23576762 Free PMC article.
References
-
- Spät A, Hunyady L. Physiol Rev. 2004;84:489. - PubMed
-
- Spät A. Mol Cell Endocrinol. 2004;217:23. - PubMed
-
- McEwan PE, Lindop GB, Kenyon CJ. Am J Physiol. 1996;271:E192. - PubMed
-
- Pawlikowski M, Gruszka A, Mucha S, Melen-Mucha G. Endocr Regul. 2001;35:139. - PubMed
-
- Tanabe A, et al. J Endocrinol Invest. 1998;21:668. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous